Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Otte

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
The American Journal of Psychiatry|December 8, 2006
No improvement of posttraumatic stress disorder symptoms with guanfacine treatmentThomas C Neylan, Maryann Lenoci, Kristin W Samuelson, et al.
BMC Psychiatry|October 12, 2023
Patient characteristics, validity of clinical diagnoses and Outcomes Associated with Suicidality in Inpatients with Symptoms of Depression (OASIS-D): design, procedures and outcomesViktor B Nöhles, Felix Bermpohl, Peter Falkai, et al.
Frontiers in Neurology|July 17, 2020
Distinct Functional Connectivity Signatures of Impaired Social Cognition in Multiple SclerosisSabrina Golde, Josephine Heine, Jana Pöttgen, et al.
JAMA Psychiatry|September 6, 2023
Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-AnalysisOle Köhler-Forsberg, Victoria Stiglbauer, Jelena Brasanac, et al.
The Lancet. Psychiatry|August 31, 2025
Clinical management of major depressive disorder with comorbid obesityNils Opel, Ruth Hanssen, Lavinia A Steinmann, et al.
BMJ Open|August 5, 2025
Treating nightmares in post-traumatic stress disorder with the α-adrenergic agents clonidine and doxazosin: protocol for a phase II randomised, double-blind, placebo-controlled parallel-group study (ClonDoTrial)Stefan Roepke, Nikola Schoofs, Kathlen Priebe, et al.
Stroke|July 7, 2025
Lesion-Network Mapping of Poststroke Depressive Symptoms: Evidence From Two Prospective Ischemic Stroke CohortsAna Sofía Ríos, Uchralt Temuulen, Ahmed A Khalil, et al.
Iscience|November 12, 2021
Reduced mitochondrial respiration in T cells of patients with major depressive disorderStefanie Gamradt, Helge Hasselmann, Aline Taenzer, et al.
Brain, Behavior, and Immunity|December 5, 2021
Immune signature of multiple sclerosis-associated depressionJelena Brasanac, Caren Ramien, Stefanie Gamradt, et al.
Journal of Affective Disorders|November 13, 2025
Symptom trajectories and their predictive factors in psychiatric inpatients with depressionJulian Herpertz, Ramona Leenings, Luise Victoria Claaß, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
The American Journal of Psychiatry|December 8, 2006
No improvement of posttraumatic stress disorder symptoms with guanfacine treatmentThomas C Neylan, Maryann Lenoci, Kristin W Samuelson, et al.
BMC Psychiatry|October 12, 2023
Patient characteristics, validity of clinical diagnoses and Outcomes Associated with Suicidality in Inpatients with Symptoms of Depression (OASIS-D): design, procedures and outcomesViktor B Nöhles, Felix Bermpohl, Peter Falkai, et al.
Frontiers in Neurology|July 17, 2020
Distinct Functional Connectivity Signatures of Impaired Social Cognition in Multiple SclerosisSabrina Golde, Josephine Heine, Jana Pöttgen, et al.
JAMA Psychiatry|September 6, 2023
Efficacy and Safety of Antidepressants in Patients With Comorbid Depression and Medical Diseases: An Umbrella Systematic Review and Meta-AnalysisOle Köhler-Forsberg, Victoria Stiglbauer, Jelena Brasanac, et al.
The Lancet. Psychiatry|August 31, 2025
Clinical management of major depressive disorder with comorbid obesityNils Opel, Ruth Hanssen, Lavinia A Steinmann, et al.
BMJ Open|August 5, 2025
Treating nightmares in post-traumatic stress disorder with the α-adrenergic agents clonidine and doxazosin: protocol for a phase II randomised, double-blind, placebo-controlled parallel-group study (ClonDoTrial)Stefan Roepke, Nikola Schoofs, Kathlen Priebe, et al.
Stroke|July 7, 2025
Lesion-Network Mapping of Poststroke Depressive Symptoms: Evidence From Two Prospective Ischemic Stroke CohortsAna Sofía Ríos, Uchralt Temuulen, Ahmed A Khalil, et al.
Iscience|November 12, 2021
Reduced mitochondrial respiration in T cells of patients with major depressive disorderStefanie Gamradt, Helge Hasselmann, Aline Taenzer, et al.
Brain, Behavior, and Immunity|December 5, 2021
Immune signature of multiple sclerosis-associated depressionJelena Brasanac, Caren Ramien, Stefanie Gamradt, et al.
Journal of Affective Disorders|November 13, 2025
Symptom trajectories and their predictive factors in psychiatric inpatients with depressionJulian Herpertz, Ramona Leenings, Luise Victoria Claaß, et al.
Pageof 21